ProtoKinetix claims breakthrough in anti-aging research

By Simon Pitman

- Last updated on GMT

Related tags Human skin color Ultraviolet

British Colombia-based biotech company ProtoKinetix says that
further scientific testing has underlined how AAGP molecules can
arrest the aging effect on the skin and prevent UV damage - a
discovery that could lead to a number of skin care and sun care
applications.

AAGP is a family of glycoproteins that have been found to provide anti-inflammatory, anti-aging and UV protection properties for the skin, which the company claims could have a major impact on the cosmetics and personal care industry.

CosmeticsDesign.com reported on the progress of the company's research back in October, highlighting the fact that it was getting closer towards providing the industry with solid evidence to prove its research in the field.

The next step has been to trial the research, a step that is said to have confirmed that the technology could ultimately slow down the aging process of human skin. The trials have been carried out in conjunction with an unnamed cosmetics company.

ProtoKinetix says that the trials have concluded that very low concentrations of AAGP molecules have proven to be a powerful additive compared to the noted anti-aging compound coenzyme Q10, and that further testing has highlighted cell integrity and cell function even within high concentrations of the cell molecule.

Furthermore, other tests concerning UV exposure have found that AAGP molecules not only help protect against UV light, but it can actually help at a molecular level to induce the repair of damaged cells.

Capitalizing on these trial results, the company says that the next step will be to launch AAGP into markets where no regulatory approval is necessary for fast tracking.

This should see the incorporation of the technology into skin care applications for its anti-oxidant and anti-aging properties, as well as a variety of sun care products for both its protection and repair properties.

In anticipation of this move the company has entered into talks with chemical companies to ramp up production of the AAGP molecule family, with a view to fulfilling six separate application developments with universities, institutions and corporations.ProtoKinetix says that the course of the manufacturing and application developments will ultimately dictate the development of the technology, but is expecting that it will also help to quickly establish a strong market value.

Related topics Skin Care

Related news

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast